[Clinical features of stage D prostatic carcinoma]. 1989

N Kobayashi, and K Yoshida, and H Saitoh, and K Tari, and T Negishi, and F Ohwada, and T Saitoh
Department of Urology, Medical Center of Saitama Medical School.

Sixty seven cases of stage D prostatic carcinoma were analyzed according to age, chief complaints, histopathological types, metastatic sites, and serum acid and alkaline phosphatase levels. In spite of metastasis, which were in 62 cases (92.5%) to bone, in 17 cases (25.4%) to lymph nodes, and in 3 cases (4.5%) to the lung, the most common chief complaints were symptoms related to the primary lesion, such as dysuria and urinary frequency. There was no significant correlation between the incidence of bone metastasis and histopathological type. However, higher incidence of lymph node metastasis was observed in the histological types of moderate and poorly differentiated adenocarcinoma than well differentiated type. When cases were divided into two groups by age, significant differences were observed between younger (64 less than or equal to years old) and older (greater than or equal to 65 years old) groups in the following points: 1) Histopathologically, well differentiated type was not recognized in the younger group, while three histological types of well, moderate and poorly differentiated adenocarcinoma, were equally distributed among the older one. 2) Although there was no significant difference in the incidence or the numbers of metastatic sites to bone between the two groups, the younger patients had less symptoms related to bone metastasis. The prominent symptoms in the younger group were complaints about voiding.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000135 Acid Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.2. Acid beta-Glycerophosphatase,Acid beta Glycerophosphatase
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

N Kobayashi, and K Yoshida, and H Saitoh, and K Tari, and T Negishi, and F Ohwada, and T Saitoh
February 1991, The Urologic clinics of North America,
N Kobayashi, and K Yoshida, and H Saitoh, and K Tari, and T Negishi, and F Ohwada, and T Saitoh
February 1983, Urology,
N Kobayashi, and K Yoshida, and H Saitoh, and K Tari, and T Negishi, and F Ohwada, and T Saitoh
January 1981, Journal of surgical oncology,
N Kobayashi, and K Yoshida, and H Saitoh, and K Tari, and T Negishi, and F Ohwada, and T Saitoh
October 1978, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
N Kobayashi, and K Yoshida, and H Saitoh, and K Tari, and T Negishi, and F Ohwada, and T Saitoh
January 1987, Progress in clinical and biological research,
N Kobayashi, and K Yoshida, and H Saitoh, and K Tari, and T Negishi, and F Ohwada, and T Saitoh
September 1986, Clinica chimica acta; international journal of clinical chemistry,
N Kobayashi, and K Yoshida, and H Saitoh, and K Tari, and T Negishi, and F Ohwada, and T Saitoh
December 1978, Cancer,
N Kobayashi, and K Yoshida, and H Saitoh, and K Tari, and T Negishi, and F Ohwada, and T Saitoh
August 2007, Expert review of anticancer therapy,
N Kobayashi, and K Yoshida, and H Saitoh, and K Tari, and T Negishi, and F Ohwada, and T Saitoh
September 1982, Journal of clinical ultrasound : JCU,
N Kobayashi, and K Yoshida, and H Saitoh, and K Tari, and T Negishi, and F Ohwada, and T Saitoh
April 2011, Oral diseases,
Copied contents to your clipboard!